Atlas Trials

Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia

Clinical trial NCT02010957 · TERMINATED

Trial details

NCT number
NCT02010957
Sponsor
Wuerzburg University Hospital
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Adrenal Neoplasia
Start date
2015-07-01
Primary completion
2021-01-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.